Found 549753 clinical trials
Sort by:
Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Not Applicable
Not yet recruiting
- Conditions
- Relapsed and Refractory DLBCL
- Interventions
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT07122609
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Neural Contributions to Exercise-Induced Hypoalgesia With Blood Flow Restriction
Not Applicable
Recruiting
- Conditions
- Healthy
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Gran Rosario
- Target Recruit Count
- 20
- Registration Number
- NCT07122011
- Locations
- 🇦🇷
University Center for Assistance, Teaching and Research (CUADI), Rosario, Santa Fe, Argentina
A Five-Day Contagious Laughter Intervention for Adult Well-being
Not Applicable
Completed
- Conditions
- Well-being
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Zayed University
- Target Recruit Count
- 100
- Registration Number
- NCT07123571
- Locations
- 🇦🇪
Zayed University, Abu Dhabi, United Arab Emirates
Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms
Recruiting
- Conditions
- Neuroendocrine (NE) TumorsEndocrine Cancer
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Uppsala University
- Target Recruit Count
- 94
- Registration Number
- NCT07121998
- Locations
- 🇸🇪
Akademiska Sjukhuset, Uppsala, Sweden
Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
Not Applicable
Not yet recruiting
- Conditions
- Recurrent or Metastatic Solid Tumors With Positive ALPP
- Interventions
- Biological: Anti ALPP CAR-T cells treatment
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Haifeng Qin
- Target Recruit Count
- 24
- Registration Number
- NCT07123493
- Locations
- 🇨🇳
Beijing GoBroad Hospital, Beijing, Beijing, China
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
Not Applicable
Not yet recruiting
- Conditions
- Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsAcetylcholine Release InhibitorsMembrane Transport ModulatorsMolecular Mechanisms of Pharmacological ActionCholinergic AgentsNeurotransmitter AgentsincobotulinumtoxinABotulinum Toxins, Type A
- Interventions
- Drug: NT 201 Placebo
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT07122193
Exercises for Pes Planus
Not Applicable
Active, not recruiting
- Conditions
- Pes Planus
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Gaziantep Islam Science and Technology University
- Target Recruit Count
- 32
- Registration Number
- NCT07123753
- Locations
- 🇹🇷
Gaziantep Islam Science and Technology University, Gaziantep, Nizip, Turkey
[Trial of device that is not approved or cleared by the U.S. FDA]
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- [Redacted]
- Registration Number
- NCT07121933
Future Osteoarthritis Treatment - Free Open Online Course for All
Not yet recruiting
- Conditions
- Osteoarthritis (OA)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Eva Ekvall-Hansson
- Target Recruit Count
- 50
- Registration Number
- NCT07122154
- Locations
- 🇸🇪
Lund university, Lund, Sweden
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
Not Applicable
Recruiting
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Interventions
- Biological: iNeo-Vac-P01 Personalized Neoantigen Peptide VaccineBiological: iNeo-Vac-T01 Personalized T Cell Injection
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Zhejiang University
- Target Recruit Count
- 20
- Registration Number
- NCT07123545
- Locations
- 🇨🇳
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China